Soluble vascular cell adhesion molecule-1 and E-selectin in patients with acute myocardial infarction treated with thrombolytic agents.

PubWeight™: 0.80‹?›

🔗 View Article (PMID 9527091)

Published in Am J Cardiol on March 15, 1998

Authors

P A Gurbel1, V L Serebruany

Author Affiliations

1: Union Memorial Hospital, Baltimore, Maryland 21218, USA.

Articles by these authors

Effects of reteplase and alteplase on platelet aggregation and major receptor expression during the first 24 hours of acute myocardial infarction treatment. GUSTO-III Investigators. Global Use of Strategies to Open Occluded Coronary Arteries. J Am Coll Cardiol (1998) 1.55

Timing of magnesium therapy affects experimental infarct size. Circulation (1995) 1.17

Usefulness of soluble and surface-bound P-selectin in detecting heightened platelet activity in patients with congestive heart failure. Am J Cardiol (1999) 1.01

Hemostatic abnormalities in patients with congestive heart failure: diagnostic significance and clinical challenge. Int J Cardiol (2000) 0.93

Statins do not affect platelet inhibition with clopidogrel during coronary stenting. Atherosclerosis (2001) 0.87

Soluble VCAM-1 and E-selectin, but not ICAM-1 discriminate endothelial injury in patients with documented coronary artery disease. Cardiology (2000) 0.86

Plasma thromboxane and prostacyclin are linear related and increased in patients presenting with acute myocardial infarction. Prostaglandins Leukot Essent Fatty Acids (1999) 0.85

Depression, coronary events, platelet inhibition, and serotonin reuptake inhibitors. Am J Cardiol (1999) 0.84

Short-term low dose intracoronary diltiazem administered at the onset of reperfusion reduces myocardial infarct size. Int J Cardiol (1997) 0.84

The effect of chronic azithromycin therapy on soluble endothelium-derived adhesion molecules in patients with coronary artery disease. J Cardiovasc Pharmacol (2000) 0.80

Paradoxical activation of major platelet receptors in the methadone-maintained patients after single pill of aspirin. Thromb Res (2001) 0.79

Noncompliance in antiplatelet trials: the AGATE trial perspective. Stroke (2004) 0.78

Aspirin in patients with coronary artery disease: is it simply irresistible? J Thromb Thrombolysis (2001) 0.78

Platelet inhibition beyond conventional antiplatelet agents: expanding role of angiotensin receptor blockers, statins and selective serotonin reuptake inhibitors. Int J Clin Pract (2006) 0.78

Pathophysiology and therapeutic modification of thrombin generation in patients with coronary artery disease. Eur J Pharmacol (2000) 0.78

Pretreatment with an inhibitor of mac-1 alters regional and systemic platelet function during ischemia-reperfusion in swine. Pharmacology (1996) 0.77

Myths and realities of P-selectin plasma levels in patients with acute myocardial infarction. Thromb Res (1997) 0.77

Decreased intraplatelet Ca2+ release and ATP secretion in pediatric nephrotic syndrome. Pediatr Nephrol (1999) 0.77

Failure of thrombin generation markers to triage patients presenting with chest pain. Cardiology (1999) 0.77

The relations of major platelet receptor expression during myocardial infarction. Monitoring efficacy of GPIIb/IIIa inhibitors by measuring P-selectin? Thromb Haemost (1999) 0.77

Depression and ischemic heart disease. Am Heart J (2000) 0.76

Role of soluble and platelet-bound P-selectin in discriminating cardiac from noncardiac chest pain at presentation in the emergency department. Am Heart J (2000) 0.76

Clinical utility of available methods for determining platelet function. Cardiology (1999) 0.76

Platelet activation as a universal trigger in the pathogenesis of acute coronary events after cocaine abuse. Swiss Med Wkly (2001) 0.76

Soluble P-selectin is not a surrogate marker for platelet P-selectin: evidence from a multicenter chest pain study group. J Thromb Thrombolysis (2000) 0.75

Monitoring platelet inhibition during chronic oral platelet glycoprotein IIb/IIIa blockade: are we missing something? Thromb Haemost (2000) 0.75

Relation of soluble and platelet P-selectin to early outcome in patients with acute myocardial infarction after thrombolytic therapy. Am J Cardiol (2001) 0.75

Clopidogrel: the future choice for preventing platelet activation during coronary stenting? Pharmacol Res (1999) 0.75

Oral platelet IIb/IIIa inhibitors: from attractive theory to clinical failures. J Thromb Thrombolysis (2000) 0.75

Storing paraformaldehyde-fixed whole blood patient samples after chronic platelet glycoprotein IIb/IIIa blockade: core laboratory considerations. Thromb Res (1999) 0.75

Platelet function and total length of intracoronary stents: is there a correlation? Thromb Res (2001) 0.75

Initial platelet activity may predict efficacy after chronic oral glycoprotein IIb/IIIa blockade: should we still consider uniform treatment regimens? Thromb Res (2000) 0.75

Reteplase but not alteplase affects early soluble PECAM-1 and P-selectin release in patients with acute myocardial infarction. Thromb Haemost (1998) 0.75

Take an aspirin or have a drink: antecedent aspirin and moderate alcohol consumption similarly affect baseline platelet characteristics in patients with acute myocardial infarction. Thromb Haemost (2000) 0.75

Assessment of platelet activity by measuring platelet-derived substances in plasma from patients with acute myocardial infarction: surprising lessons from the GUSTO-III Platelet Study. Thromb Res (1999) 0.75

Profound inhibition of GPIb, GPIIb/IIIa, PECAM-1, CD63, and CD107 in a chronic drug addict: selecting controls for platelet flow cytometry in the inner city hospital. Thromb Res (2001) 0.75

Combining necrosis and platelet markers for perfecting myocardial infarction rule out: how close are we? Cardiology (2000) 0.75

Platelet function and fibrinolytic agents: two sides of a coin? Cardiology (2001) 0.75

How magnesium therapy may influence clinical outcome in acute myocardial infarction: review of potential mechanisms. Coron Artery Dis (1996) 0.75

Effect of magnesium sulphate infusion on ex vivo platelet aggregation in swine. Magnes Res (1993) 0.75

Increased baseline levels of platelet P-selectin, and platelet-endothelial cell adhesion molecule-1 in patients with acute myocardial infarction as predictors of unsuccessful thrombolysis. Coron Artery Dis (1998) 0.75

Baseline platelet aggregation and major receptor expression predict subsequent activity following thrombolysis for acute myocardial infarction. Scand Cardiovasc J (2000) 0.75

Amount of paraformaldehyde for sample fixation markedly affects the quality of platelet assessment by flow cytometry: experience from two clinical trials. Thromb Res (2000) 0.75